Improving health equity in cardiometabolic diseases in the Deep South
Investigator Development Core
This study is all about improving health for people in Alabama, Mississippi, and Louisiana by training new researchers to find the best ways to help those at risk for heart and metabolic diseases, making sure that the right solutions reach the right people when they need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10884911 on NIH RePORTER |
What this research studies
This research focuses on promoting health equity and reducing the burden of cardiometabolic diseases in the Deep South, particularly in Alabama, Mississippi, and Louisiana. It aims to grow and diversify the workforce capable of conducting impactful research on effective health interventions. By mentoring new investigators, the project seeks to apply a precision public health approach, ensuring that the right interventions reach the right populations at the right times. The research involves collaboration among multiple academic institutions and community stakeholders to address health disparities.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older living in the Deep South who are affected by cardiometabolic diseases.
Not a fit: Patients outside the Deep South region or those not affected by cardiometabolic diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective health interventions that significantly improve outcomes for individuals suffering from cardiometabolic diseases.
How similar studies have performed: Previous research has shown success in addressing health disparities through community-based interventions, indicating that this approach has potential for positive outcomes.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Gutierrez, Orlando M — University of Alabama at Birmingham
- Study coordinator: Gutierrez, Orlando M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.